August 3, 2021
1 min read

Pfizer, Moderna raise Covid-19 vaccine prices in EU


The supply contracts are being renewed as Europe is anxious to secure supplies for potential booster shots in the face of the spread of the highly infectious Delta variant…reports Asian Lite News.

US drug makers Pfizer and Moderna have increased the prices of their mRNA-based vaccines against Covid-19 for the European market, the media reported.

According to the new contracts, a Pfizer shot will now cost 19.50 euros against 15.50 euros previously, while a Moderna jab has been priced at 21.49 euros a dose, from about 19 euros in the first procurement deal, The Financial Times reported.

The supply contracts are being renewed as Europe is anxious to secure supplies for potential booster shots in the face of the spread of the highly infectious Delta variant.

Further, the terms of the deals, struck this year for a total of up to 2.1 billion shots until 2023, were renegotiated after phase 3 trial data showed the two companies’ mRNA vaccines had higher efficacy rates than shots developed by Oxford/AstraZeneca and Johnson & Johnson, the report said.

The companies had capitalised on their market power and deployed the “usual pharma rhetoric… Vaccines work so they increased the ‘value’,” the report quoted an official close to the negotiations official.

Riding on the success of its Covid vaccine, Pfizer, last week, raised its annual vaccine revenue to $33.5 billion in 2021, up from the previously projected $26 billion.

Prices for higher-income countries were “comparable”, with middle-income countries charged about half and lower-income countries paying cost, Chief executive Albert Bourla was quoted as saying.

Moderna is expected to announce the second quarter financial results this week. According to forecasts compiled by Airfinity, a life sciences consultancy, the sales of Pfizer’s Covid jab will hit 47.1 billion euros with Moderna’s reaching 25.2 billion euros, the FT reported.

On the other hand, sales of Oxford/AstraZeneca’s Covid jab — the largest vaccine supplied to low-income countries — is expected to rise to 12.6 billion euros in 2022, it added.

ALSO READ-‘Pfizer, AZ vax antibodies may drop 50% in 3 months’

READ MORE-Pfizer recommends 3rd Covid shot for Delta variant

Previous Story

Scores of thermal power plants not complying with emission norms

Next Story

EU will not recognise Taliban if they gain power by force

Latest from -Top News

Qatar: No Set Deadline for Gaza Talks

A new round of indirect talks between Hamas and Israel resumed on July 6 in Doha amid international efforts to end the conflict that has devastated Gaza…reports Asian Lite News Indirect talks

Trump: ‘Zelenskiy Shouldn’t Target Moscow’

When asked whether the United States would send long-range missiles to Ukraine, Trump replied, “No, we’re not looking to do that.”…reports Asian Lite News US President Donald Trump denied encouraging Ukraine to

India to Aid Ray Home Restoration in Bangladesh

India noted that the property, currently owned by the Government of Bangladesh, “is in a state of disrepair”….reports Asian Lite News The Government of India has expressed deep regret over the ongoing

Sri Lanka, India Deepen Ties

The delegation, including 24 leaders from across 14 political parties of Sri Lanka, began their two-week visit to India on Wednesday….reports Asian Lite News A 24-member Sri Lankan delegation met Foreign Secretary

Jaishankar Flags Pahalgam Attack at SCO Meet

In his address, EAM Jaishankar spotlighted that the meeting is taking place at a time of “considerable disorder” in the international system….reports Asian Lite News Highlighting the dastardly April 22 terrorist attack
Go toTop

Don't Miss

EU to supply 20mn additional vaccine doses to fight Omicron

These doses come on top of the already scheduled 195

India to share Covid vax tech with 50 countries

India to share the technology ‘free of cost’ with more